British drug manufacturer GlaxoSmithKline (GSK), which makes the recalled diabetes drug Avandia, has set aside a $3.4 billion “to pay for United States government investigations and product liability cases over its marketing of” Avandia.
Click here to read the entire New York Times article.
This set aside is in addition to the $2.36 billion charge taken last summer to settle about 10,000 of 13,000 Avandia product liability lawsuits it was facing in the United States, as well as investigations over its antidepressant Paxil and manufacturing problems in Puerto Rico.
The article continued: “Avandia has been controversial since a 2007 analysis linked it with a 43 percent increase in the risk of heart attacks.”
The Brandi Law Firm is representing people that have been adversely effected by Avandia. Click here to learn more about The Brandi Law Firm Avandia Attorneys.